Gregg Stanwood
Last active: 1/20/2015

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Evidence against dopamine D1/D2 receptor heteromers. Frederick AL, Yano H, Trifilieff P, Vishwasrao HD, Biezonski D, Mészáros J, Urizar E, Sibley DR, Kellendonk C, Sonntag KC, Graham DL, Colbran RJ, Stanwood GD, Javitch JA (2015) Mol Psychiatry 20(11): 1373-85
    › Primary publication · 25560761 (PubMed) · PMC4492915 (PubMed Central)
  2. Loss of dopamine D2 receptors increases parvalbumin-positive interneurons in the anterior cingulate cortex. Graham DL, Durai HH, Garden JD, Cohen EL, Echevarria FD, Stanwood GD (2015) ACS Chem Neurosci 6(2): 297-305
    › Primary publication · 25393953 (PubMed) · PMC4372074 (PubMed Central)
  3. The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants. Mergy MA, Gowrishankar R, Gresch PJ, Gantz SC, Williams J, Davis GL, Wheeler CA, Stanwood GD, Hahn MK, Blakely RD (2014) Proc Natl Acad Sci U S A 111(44): E4779-88
    › Primary publication · 25331903 (PubMed) · PMC4226116 (PubMed Central)
  4. Inhalable curcumin: offering the potential for translation to imaging and treatment of Alzheimer's disease. McClure R, Yanagisawa D, Stec D, Abdollahian D, Koktysh D, Xhillari D, Jaeger R, Stanwood G, Chekmenev E, Tooyama I, Gore JC, Pham W (2015) J Alzheimers Dis 44(1): 283-95
    › Primary publication · 25227316 (PubMed) · PMC4297252 (PubMed Central)
  5. Rictor/mTORC2 facilitates central regulation of energy and glucose homeostasis. Kocalis HE, Hagan SL, George L, Turney MK, Siuta MA, Laryea GN, Morris LC, Muglia LJ, Printz RL, Stanwood GD, Niswender KD (2014) Mol Metab 3(4): 394-407
    › Primary publication · 24944899 (PubMed) · PMC4060224 (PubMed Central)
  6. Developmental consequences of fetal exposure to drugs: what we know and what we still must learn. Ross EJ, Graham DL, Money KM, Stanwood GD (2015) Neuropsychopharmacology 40(1): 61-87
    › Primary publication · 24938210 (PubMed) · PMC4262892 (PubMed Central)
  7. Developmental origins of brain disorders: roles for dopamine. Money KM, Stanwood GD (2013) Front Cell Neurosci : 260
    › Primary publication · 24391541 (PubMed) · PMC3867667 (PubMed Central)
  8. Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder. Mergy MA, Gowrishankar R, Davis GL, Jessen TN, Wright J, Stanwood GD, Hahn MK, Blakely RD (2014) Neurochem Int : 56-70
    › Primary publication · 24332984 (PubMed) · PMC4177817 (PubMed Central)
  9. Transgenic overexpression of the presynaptic choline transporter elevates acetylcholine levels and augments motor endurance. Holmstrand EC, Lund D, Cherian AK, Wright J, Martin RF, Ennis EA, Stanwood GD, Sarter M, Blakely RD (2014) Neurochem Int : 217-28
    › Primary publication · 24274995 (PubMed) · PMC4104494 (PubMed Central)
  10. Moving beyond energy homeostasis: new roles for glucagon-like peptide-1 in food and drug reward. Reddy IA, Stanwood GD, Galli A (2014) Neurochem Int : 49-55
    › Primary publication · 24140429 (PubMed) · PMC4120871 (PubMed Central)
  11. Neuron-specific deletion of peroxisome proliferator-activated receptor delta (PPARδ) in mice leads to increased susceptibility to diet-induced obesity. Kocalis HE, Turney MK, Printz RL, Laryea GN, Muglia LJ, Davies SS, Stanwood GD, McGuinness OP, Niswender KD (2012) PLoS One 7(8): e42981
    › Primary publication · 22916190 (PubMed) · PMC3423438 (PubMed Central)
  12. Subtle biobehavioral effects produced by paternal cocaine exposure. Killinger CE, Robinson S, Stanwood GD (2012) Synapse 66(10): 902-8
    › Primary publication · 22807092 (PubMed) · PMC3432506 (PubMed Central)
  13. Retinal dopamine mediates multiple dimensions of light-adapted vision. Jackson CR, Ruan GX, Aseem F, Abey J, Gamble K, Stanwood G, Palmiter RD, Iuvone PM, McMahon DG (2012) J Neurosci 32(27): 9359-68
    › Primary publication · 22764243 (PubMed) · PMC3400466 (PubMed Central)
  14. Neurobehavioral phenotyping of G(αq) knockout mice reveals impairments in motor functions and spatial working memory without changes in anxiety or behavioral despair. Frederick AL, Saborido TP, Stanwood GD (2012) Front Behav Neurosci : 29
    › Primary publication · 22723772 (PubMed) · PMC3377978 (PubMed Central)
  15. Haploinsufficiency of the E3 ubiquitin ligase C-terminus of heat shock cognate 70 interacting protein (CHIP) produces specific behavioral impairments. McLaughlin B, Buendia MA, Saborido TP, Palubinsky AM, Stankowski JN, Stanwood GD (2012) PLoS One 7(5): e36340
    › Primary publication · 22606257 (PubMed) · PMC3350526 (PubMed Central)
  16. Development of hyperactivity and anxiety responses in dopamine transporter-deficient mice. Carpenter AC, Saborido TP, Stanwood GD (2012) Dev Neurosci 34(2-3): 250-7
    › Primary publication · 22572477 (PubMed)
  17. Exendin-4 decreases amphetamine-induced locomotor activity. Erreger K, Davis AR, Poe AM, Greig NH, Stanwood GD, Galli A (2012) Physiol Behav 106(4): 574-8
    › Primary publication · 22465309 (PubMed) · PMC3348974 (PubMed Central)
  18. Loss of Thr286 phosphorylation disrupts synaptic CaMKIIα targeting, NMDAR activity and behavior in pre-adolescent mice. Gustin RM, Shonesy BC, Robinson SL, Rentz TJ, Baucum AJ, Jalan-Sakrikar N, Winder DG, Stanwood GD, Colbran RJ (2011) Mol Cell Neurosci 47(4): 286-92
    › Primary publication · 21627991 (PubMed) · PMC3149813 (PubMed Central)
  19. Operant sensation seeking requires metabotropic glutamate receptor 5 (mGluR5). Olsen CM, Childs DS, Stanwood GD, Winder DG (2010) PLoS One 5(11): e15085
    › Primary publication · 21152045 (PubMed) · PMC2994905 (PubMed Central)
  20. Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice. Siuta MA, Robertson SD, Kocalis H, Saunders C, Gresch PJ, Khatri V, Shiota C, Kennedy JP, Lindsley CW, Daws LC, Polley DB, Veenstra-Vanderweele J, Stanwood GD, Magnuson MA, Niswender KD, Galli A (2010) PLoS Biol 8(6): e1000393
    › Primary publication · 20543991 (PubMed) · PMC2882427 (PubMed Central)
  21. Specificity of prenatal cocaine exposure effects on cortical interneurons is independent from dopamine D1 receptor co-localization. Thompson BL, Stanwood GD, Levitt P (2010) J Chem Neuroanat 39(4): 228-34
    › Primary publication · 20080176 (PubMed) · PMC2850967 (PubMed Central)
  22. Dystrophic dendrites in prefrontal cortical pyramidal cells of dopamine D1 and D2 but not D4 receptor knockout mice. Wang HD, Stanwood GD, Grandy DK, Deutch AY (2009) Brain Res : 58-64
    › Primary publication · 19747903 (PubMed) · PMC2783753 (PubMed Central)
  23. Combination of diOlistic labeling with retrograde tract tracing and immunohistochemistry. Neely MD, Stanwood GD, Deutch AY (2009) J Neurosci Methods 184(2): 332-6
    › Primary publication · 19712695 (PubMed) · PMC2796483 (PubMed Central)
  24. Manganese exposure is cytotoxic and alters dopaminergic and GABAergic neurons within the basal ganglia. Stanwood GD, Leitch DB, Savchenko V, Wu J, Fitsanakis VA, Anderson DJ, Stankowski JN, Aschner M, McLaughlin B (2009) J Neurochem 110(1): 378-89
    › Primary publication · 19457100 (PubMed) · PMC2737271 (PubMed Central)
  25. Drugs, biogenic amine targets and the developing brain. Frederick AL, Stanwood GD (2009) Dev Neurosci 31(1-2): 7-22
    › Primary publication · 19372683 (PubMed) · PMC2786771 (PubMed Central)
  26. Glutamate spillover augments GABA synthesis and release from axodendritic synapses in rat hippocampus. Stafford MM, Brown MN, Mishra P, Stanwood GD, Mathews GC (2010) Hippocampus 20(1): 134-44
    › Primary publication · 19338018 (PubMed) · PMC2810457 (PubMed Central)
  27. ADAR1 and ADAR2 expression and editing activity during forebrain development. Jacobs MM, Fogg RL, Emeson RB, Stanwood GD (2009) Dev Neurosci 31(3): 223-37
    › Primary publication · 19325227 (PubMed) · PMC2692045 (PubMed Central)
  28. Prenatal exposure to drugs: effects on brain development and implications for policy and education. Thompson BL, Levitt P, Stanwood GD (2009) Nat Rev Neurosci 10(4): 303-12
    › Primary publication · 19277053 (PubMed) · PMC2777887 (PubMed Central)
  29. Differences in aggressive behavior and in the mesocorticolimbic DA system between A/J and BALB/cJ mice. Couppis MH, Kennedy CH, Stanwood GD (2008) Synapse 62(10): 715-24
    › Primary publication · 18651644 (PubMed)
  30. Pleiotropic effects of neurotransmission during development: modulators of modularity. Thompson BL, Stanwood GD (2009) J Autism Dev Disord 39(2): 260-8
    › Primary publication · 18648918 (PubMed) · PMC2777884 (PubMed Central)
  31. Protein-protein interactions and dopamine D2 receptor signaling: a calcium connection. Stanwood GD (2008) Mol Pharmacol 74(2): 317-9
    › Primary publication · 18511653 (PubMed)
  32. Ontogenetic quinpirole treatment produces long-lasting decreases in the expression of Rgs9, but increases Rgs17 in the striatum, nucleus accumbens and frontal cortex. Maple AM, Perna MK, Parlaman JP, Stanwood GD, Brown RW (2007) Eur J Neurosci 26(9): 2532-8
    › Primary publication · 17970732 (PubMed)
  33. Pharmacokinetic profile of cocaine following intravenous administration in the female rabbit. Parlaman JP, Thompson BL, Levitt P, Stanwood GD (2007) Eur J Pharmacol 563(1-3): 124-9
    › Primary publication · 17383635 (PubMed) · PMC1945095 (PubMed Central)
  34. Waved-1 mutant mice are hypersensitive to the locomotor actions of cocaine. Stanwood GD, Levitt P (2007) Synapse 61(4): 259-62
    › Primary publication · 17230552 (PubMed)
  35. Prenatal exposure to cocaine produces unique developmental and long-term adaptive changes in dopamine D1 receptor activity and subcellular distribution. Stanwood GD, Levitt P (2007) J Neurosci 27(1): 152-7
    › Primary publication · 17202482 (PubMed) · PMC6672298 (PubMed Central)
  36. Genetic or pharmacological inactivation of the dopamine D1 receptor differentially alters the expression of regulator of G-protein signalling (Rgs) transcripts. Stanwood GD, Parlaman JP, Levitt P (2006) Eur J Neurosci 24(3): 806-18
    › Primary publication · 16930410 (PubMed)
  37. Prenatal cocaine exposure specifically alters spontaneous alternation behavior. Thompson BL, Levitt P, Stanwood GD (2005) Behav Brain Res 164(1): 107-16
    › Primary publication · 16054247 (PubMed)
  38. Anatomical abnormalities in dopaminoceptive regions of the cerebral cortex of dopamine D1 receptor mutant mice. Stanwood GD, Parlaman JP, Levitt P (2005) J Comp Neurol 487(3): 270-82
    › Primary publication · 15892099 (PubMed)